Clinical trial
Treatment of PED With AMT and Autologous Serum
NCT00238862 · King Khaled Eye Specialist Hospital, Other · Completed
Key facts
| NCT number | NCT00238862 |
|---|---|
| Title | Treatment of PED With AMT and Autologous Serum |
| Official title | Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects |
| Lead sponsor | King Khaled Eye Specialist Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Corneal Epithelial Defect |
| Intervention type | Drug, Procedure |
| Interventions | Amniotic membrane transplantation, Autologous serum/BSS 20% |
| Enrollment | 180 |
| Start date | Oct 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Oct 14, 2005 |
| Last update posted | Dec 2, 2021 |
| Countries | Saudi Arabia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: